0.7285
+0.0280
+(4.00%)
As of 8:01:01 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-43,080.0000
-62,054.0000
-60,079.0000
-47,941.0000
-14,709.0000
Investing Cash Flow
-6,094.0000
3,077.0000
-16,967.0000
-1,816.0000
-307.0000
Financing Cash Flow
34,702.0000
20,881.0000
59,475.0000
120,676.0000
31,611.0000
End Cash Position
39,005.0000
39,462.0000
77,563.0000
95,109.0000
24,190.0000
Capital Expenditure
-6,094.0000
-10,476.0000
-4,457.0000
-939.0000
-307.0000
Issuance of Capital Stock
--
20,804.0000
59,567.0000
129,211.0000
37,822.0000
Issuance of Debt
--
500.0000
500.0000
--
921.0000
Repayment of Debt
--
--
--
-10.0000
-5,649.0000
Free Cash Flow
-49,174.0000
-72,530.0000
-64,536.0000
-48,880.0000
-15,016.0000
12/31/2020 - 12/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0OT.F Ocular Therapeutix, Inc.
7.41
-0.96%
VLA.VI Valneva SE
2.7660
+15.54%
0K4.F Akero Therapeutics, Inc.
54.08
+4.77%
IVVD Invivyd, Inc.
0.3900
+1.22%
GOVX GeoVax Labs, Inc.
1.9500
+3.72%
SGMO Sangamo Therapeutics, Inc.
1.2300
+8.85%
NVAX Novavax, Inc.
9.01
+2.27%
PPCB Propanc Biopharma, Inc.
25.00
0.00%
RXRX Recursion Pharmaceuticals, Inc.
7.69
+7.40%
AKRO Akero Therapeutics, Inc.
55.36
+2.52%